Search Results for “JCAR015” – Page 2 – Endpoints News

SIGN UP

search results for: JCAR015

After Kite Pharma stuns analysts with news of a death in lead CAR-T study, safety questions sour launch forecast

7 years ago

One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm

7 years ago

Scoop: Juno recruits Sunil Agarwal as R&D chief, opening a Bay Area facility in research revamp

8 years ago

There has to be a better way to handle Duchenne drugs; Let's get to the bottom of the Juno debacle

8 years ago

Months after another lethal setback, Juno finally opts to kill lead CAR-T

8 years ago

Novartis adds opthalmology buyout in year-end deal spree; Tesaro gets a speedy FDA review for niraparib

8 years ago

Juno gets some badly needed relief after a glimpse of upbeat early data on JCAR017

8 years ago

In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program

8 years ago

Lethally severe neurotoxicity continues to haunt Juno’s CAR-T pipeline

8 years ago

Juno and the FDA screwed up. People died. What now?

8 years ago

The 10 most popular reports in Endpoints News — so far

8 years ago

Two more patients die as Juno’s lead CAR-T turns lethal again; trial halted

8 years ago

Adaptimmune looks to salvage ovarian cancer study by adding fludarabine to prep patients

8 years ago

Just how confident is Arie Belldegrun about Kite's position in the turbulent CAR-T race? He's glad you asked.

8 years ago

Stung by patient deaths, a small Juno study points to a Goldilocks formula for CAR-T

8 years ago

Scoop: Novartis disbands its pioneering cell and gene therapy unit

8 years ago

Thumbs Up. Thumbs Down: On rookie mistakes, a class action suit and getting past failure

8 years ago

Controversial patient deaths in CAR-T study spur a class action suit against Juno

8 years ago

First page Previous page 123 Next page Last page

latest

Most read

J&J's AI head jumps to Recursion; Doug Williams resigns as Sana's R&D chief

11 hours ago

Takeda wins label expansion for subcutaneous Entyvio, creating 'flexibility' for Crohn's patients

4 hours ago

CSL Vifor proposes a marketing campaign to settle European Commission investigation

4 hours ago

Senators want to know more on why Novo is discontinuing its insulin Levemir

4 hours ago

Califf talks bolstering domestic drug manufacturing, foreign inspections at House hearing

5 hours ago

see latest stream